AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
30 Apr 2003 11:00 AM
RNS
Directorate Change
30 Apr 2003 10:00 AM
RNS
1st Quarter Results
30 Apr 2003 10:00 AM
RNS
1st Quarter Results
22 Apr 2003 04:47 PM
RNS
Capital Group
02 Apr 2003 03:51 PM
RNS
Exanta
01 Apr 2003 07:00 AM
RNS
Nexium
01 Apr 2003 07:00 AM
RNS
Purchase of Own Securities
31 Mar 2003 07:00 AM
RNS
Purchase of Own Securities
26 Mar 2003 04:00 PM
RNS
Director Shareholding
13 Mar 2003 07:13 AM
RNS
Purchase of Own Securities
11 Mar 2003 07:00 AM
RNS
Purchase of Own Securities
10 Mar 2003 07:00 AM
RNS
Crestor MRP Completion
10 Mar 2003 07:00 AM
RNS
Purchase of Own Securities
07 Mar 2003 07:00 AM
RNS
Purchase of Own Securities
05 Mar 2003 07:00 AM
RNS
Purchase of Own Securities
03 Mar 2003 07:00 AM
RNS
Crestor in Europe
03 Mar 2003 07:00 AM
RNS
Purchase of Own Securities
27 Feb 2003 12:21 PM
RNS
Annual Report and Accounts
26 Feb 2003 07:00 AM
RNS
Purchase of Own Securities
19 Feb 2003 07:00 AM
RNS
Crestor
18 Feb 2003 07:00 AM
RNS
Research Update: AZD3582
17 Feb 2003 07:00 AM
RNS
Exanta Sportif
13 Feb 2003 07:01 AM
RNS
Crestor
11 Feb 2003 09:00 AM
RNS
Iressa
30 Jan 2003 11:00 AM
RNS
Final Results (part 2 of 2)
30 Jan 2003 11:00 AM
RNS
Final Results (part 1 of 2)
29 Jan 2003 09:00 AM
RNS
Notice of Results
14 Jan 2003 04:00 PM
RNS
Capital Group
10 Jan 2003 03:00 PM
RNS
Capital Group
09 Jan 2003 03:00 PM
RNS
Update on Iressa
02 Jan 2003 01:30 PM
RNS
Seroquel
23 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
20 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
19 Dec 2002 07:09 AM
RNS
Casodex
19 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
16 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
13 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
12 Dec 2002 10:00 AM
RNS
Omeprazole Judgment
12 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
11 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
06 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
05 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
04 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
02 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
29 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
28 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
27 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
26 Nov 2002 04:07 PM
RNS
Director Shareholding
26 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
25 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100